Serum Exosomal EphA2 is a Prognostic Biomarker in Patients with Pancreatic Cancer

References

• Siegel RL , Miller KD , Jemal A . Cancer statistics, 2019. CA Cancer J Clin . 2019;69:7–34. doi:10.3322/caac.21551 30620402
   PubMed Web of Science ®Google Scholar
• Vincent A , Herman J , Schulick R , et al. Pancreatic cancer. Lancet . 2011;378:607–620. doi:10.1016/S0140-6736(10)62307-0 21620466
   PubMed Web of Science ®Google Scholar
• Zhao H , Wang Q , Wang X , et al. Correlation between RAB27B and p53 expression and overall survival in pancreatic cancer. Pancreas . 2016;45(2):204–210. doi:10.1097/MPA.0000000000000453 26418905
   PubMed Web of Science ®Google Scholar
• Peinado H , Aleckovic M , Lavotshkin S , et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med . 2012;18:883–891. doi:10.1038/nm.2753 22635005
   PubMed Web of Science ®Google Scholar
• Meldolesi J . Exosomes and ectosomes in intercellular communication. Curr Biol . 2018;28:R435–R444. doi:10.1016/j.cub.2018.01.059 29689228
   PubMed Web of Science ®Google Scholar
• Kahlert C , Kalluri R . Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med . 2013;91(4):431–437. doi:10.1007/s00109-013-1020-6 23519402
   PubMed Web of Science ®Google Scholar
• Costa-Silva B , Aiello NM , Ocean AJ , et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol . 2015;17(6):816–826. doi:10.1038/ncb3169 25985394
   PubMed Web of Science ®Google Scholar
• Liu W , Hu J , Zhou K , et al. Serum exosomal miR-125b is a novel prognostic marker for hepatocellular carcinoma. Onco Targets Ther . 2017;10:3843–3851. doi:10.2147/OTT.S140062 28814883
   PubMed Web of Science ®Google Scholar
• Sun L , Liu X , Pan B , et al. Serum exosomal miR-122 as a potential diagnostic and prognostic biomarker of colorectal cancer with liver metastasis. J Cancer . 2020;11(3):630–637. doi:10.7150/jca.33022 31942186
   PubMed Web of Science ®Google Scholar
• Bryant RJ , Pawlowski T , Catto JW , et al. Changes in circulating microRNA levels associated with prostate cancer. Br J Cancer . 2012;106(4):768–774. doi:10.1038/bjc.2011.595 22240788
   PubMed Web of Science ®Google Scholar
• Miao B , Ji Z , Tan L , et al. EPHA2 is a mediator of vemurafenib resistance and a novel therapeutic target in melanoma. Cancer Discov . 2015;5:274–287. doi:10.1158/2159-8290.CD-14-0295 25542448
   PubMed Web of Science ®Google Scholar
• Okuyama T , Sakamoto R , Kumagai K , et al. EPHA2 antisense RNA modulates EPHA2 mRNA levels in basal-like/triple-negative breast cancer cells. Biochimie . 2020;179:169–180. doi:10.1016/j.biochi.2020.10.002 33022313
   PubMed Web of Science ®Google Scholar
• Lu C , Shahzad MM , Wang H , et al. EphA2 overexpression promotes ovarian cancer growth. Cancer Biol Ther . 2008;7:1098–1103. doi:10.4161/cbt.7.7.6168 18443431
   PubMed Web of Science ®Google Scholar
• Fan J , Wei Q , Koay EJ , et al. Chemoresistance transmission via exosome-mediated EphA2 transfer in pancreatic cancer. Theranostics . 2018;8:5986–5994. doi:10.7150/thno.26650 30613276
   PubMed Web of Science ®Google Scholar
• Wei Q , Wei LJ , Zhang JY , et al. EphA2-enriched exosomes promote cell migration and are a potential diagnostic serum marker in pancreatic cancer. Mol Med Rep . 2020;22(4):2941–2947. doi:10.3892/mmr.2020.11384 32945400
   PubMed Web of Science ®Google Scholar
• Wei Q , Zhang J , Li Z , et al. Serum Exo-EphA2 as a potential diagnostic biomarker for pancreatic cancer. Pancreas . 2020;49(9):1213–1219. doi:10.1097/MPA.0000000000001660 32898008
   PubMed Web of Science ®Google Scholar
• Fu Z , Jiao Y , Li Y , et al. TYMS presents a novel biomarker for diagnosis and prognosis in patients with pancreatic cancer. Medicine . 2019;98(51):e18487. doi:10.1097/MD.0000000000018487 31861032
   PubMed Web of Science ®Google Scholar
• Drouillard A , Puleo F , Bachet JB , et al. DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer. Br J Cancer . 2016;115(10):1245–1252. doi:10.1038/bjc.2016.319 27755532
   PubMed Web of Science ®Google Scholar
• Deng GC , Yan H , Guo ZP , et al. Correlation between baseline serum tumor markers and clinical characteristic factors in patients with advanced pancreatic cancer. Onco Targets Ther . 2020;13:11151–11163. doi:10.2147/OTT.S269720 33173307
   PubMed Web of Science ®Google Scholar
• Ma W , Li T , Wu S , et al. LOX and ACSL5 as potential relapse markers for pancreatic cancer patients. Cancer Biol Ther . 2019;20(6):787–798. doi:10.1080/15384047.2018.1564565 30712446
   PubMed Web of Science ®Google Scholar
• Steinbichler TB , Dudás J , Riechelmann H , et al. The role of exosomes in cancer metastasis. Semin Cancer Biol . 2017;44:170–181. doi:10.1016/j.semcancer.2017.02.006 28215970
   PubMed Web of Science ®Google Scholar
• Becker A , Thakur BK , Weiss JM , et al. Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Cancer Cell . 2016;30(6):836–848. doi:10.1016/j.ccell.2016.10.009 27960084
   PubMed Web of Science ®Google Scholar
• Mashouri L , Yousefi H , Aref AR , et al. Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance. Mol Cancer . 2019;18(1):75. doi:10.1186/s12943-019-0991-5 30940145
   PubMed Web of Science ®Google Scholar
• Zou SL , Chen YL , Ge ZZ , et al. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer. Cancer Biomark . 2019;26(1):69–77. doi:10.3233/CBM-190156 31306108
   PubMed Web of Science ®Google Scholar
• Lv S , Wang Y , Xu W , et al. Serum exosomal miR-17-5p as a promising biomarker diagnostic biomarker for breast cancer. Clin Lab . 2020;66(9). doi:10.7754/Clin.Lab.2020.200127.
   Web of Science ®Google Scholar
• Øverbye A , Skotland T , Koehler CJ , et al. Identification of prostate cancer biomarkers in urinary exosomes. Oncotarget . 2015;6(30):30357–30376. doi:10.18632/oncotarget.4851 26196085
   PubMed Web of Science ®Google Scholar
• Zhuo C , Yi T , Pu J , et al. Exosomal linc-FAM138B from cancer cells alleviates hepatocellular carcinoma progression via regulating miR-765. Aging . 2020;12(24):26236–26247. doi:10.18632/aging.202430 33401249
   PubMedGoogle Scholar
• London M , Gallo E . The EphA2 and cancer connection: potential for immune-based interventions. Mol Biol Rep . 2020;47(10):8037–8048. doi:10.1007/s11033-020-05767-y 32990903
   PubMed Web of Science ®Google Scholar
• Huang C , Yuan W , Lai C , et al. EphA2-to-YAP pathway drives gastric cancer growth and therapy resistance. Int J Cancer . 2020;146(7):1937–1949. doi:10.1002/ijc.32609 31376289
   PubMed Web of Science ®Google Scholar
• Kinch MS , Carles-Kinch K . Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer. Clin Exp Metastasis . 2003;20:59–68. doi:10.1023/A:1022546620495 12650608
   PubMed Web of Science ®Google Scholar
• Yadav D , Lowenfels AB . The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology . 2013;144(6):1252–1261. doi:10.1053/j.gastro.2013.01.068 23622135
   PubMed Web of Science ®Google Scholar